OPHC(OPHC)
OPHC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $68M | $80M |
| Low | $68M | $80M |
| High | $68M | $80M |
| EBITDA Avg | $19M | $22M |
| Low | $19M | $22M |
| High | $19M | $22M |
| EBIT Avg | $18M | $21M |
| Low | $18M | $21M |
| High | $18M | $21M |
| Net Income Avg | $14M | $16M |
| Low | $14M | $16M |
| High | $14M | $16M |
| EPS Avg | $1.16 | $1.30 |
| Low | $1.16 | $1.30 |
| High | $1.16 | $1.30 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $18M | $18M | $18M | $21M | $23M | $26M |
| Low | $18M | $18M | $18M | $21M | $23M | $26M |
| High | $18M | $18M | $18M | $21M | $23M | $26M |
| EBITDA Avg | $5M | $5M | $5M | $6M | $6M | $7M |
| Low | $5M | $5M | $5M | $6M | $6M | $7M |
| High | $5M | $5M | $5M | $6M | $6M | $7M |
| EBIT Avg | $5M | $5M | $5M | $5M | $6M | $7M |
| Low | $5M | $5M | $5M | $5M | $6M | $7M |
| High | $5M | $5M | $5M | $5M | $6M | $7M |
| Net Income Avg | $4M | $4M | $4M | $4M | $4M | $4M |
| Low | $4M | $4M | $4M | $4M | $4M | $4M |
| High | $4M | $4M | $4M | $4M | $4M | $4M |
| EPS Avg | $0.31 | $0.31 | $0.31 | $0.32 | $0.33 | $0.34 |
| Low | $0.31 | $0.31 | $0.31 | $0.32 | $0.33 | $0.34 |
| High | $0.31 | $0.31 | $0.31 | $0.32 | $0.33 | $0.34 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |